Common Contracts

KURA ONCOLOGY, INC. REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • March 12th, 2015 • Kura Oncology, Inc. • Blank checks • New York

• Contract Type
  Registration Rights Agreement
• Filed
  March 12th, 2015
• Company
  Kura Oncology, Inc.
• Industry
  Blank checks
• Jurisdiction
  New York

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of March 6, 2015, by and among (i) Kura Oncology, Inc., a Delaware corporation (the “Company”), (ii) each person listed on Schedule A attached hereto (together with any transferees who become parties hereto as “Investors” pursuant to Section 8(f), each individually, an “Investor” and collectively, the “Investors”), (iii) each officer or director of the Company or holder of Outstanding Capital Stock (as defined below) who becomes a party hereto as an “Existing Stockholder” by signing Exhibit A attached hereto, as listed on Schedule B (together with any transferees who become parties hereto as “Existing Stockholders” pursuant to Section 8(f), each individually, an “Existing Stockholder” and collectively, the “Existing Stockholders”), and (iv) Zeta Acquisition Corp. III, a Delaware corporation (“Zeta”), but only for purposes of assuming all of the Company’s rights, duties and obligations hereunder pursuant to Section 8. The

INTRA-CELLULAR THERAPIES, INC. REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • September 5th, 2013 • Intra-Cellular Therapies, Inc. • Blank checks • New York

• Contract Type
  Registration Rights Agreement
• Filed
  September 5th, 2013
• Company
  Intra-Cellular Therapies, Inc.
• Industry
  Blank checks
• Jurisdiction
  New York

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of August 29, 2013, by and among (i) Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), (ii) each person listed on Schedule A attached hereto (together with any transferees who become parties hereto as “Investors” pursuant to Section 8(f), each individually, an “Investor” and collectively, the “Investors”), (iii) each officer or director of the Company or holder of Outstanding Capital Stock (as defined below) who becomes a party hereto as an “Existing Stockholder” by signing Exhibit A attached hereto, as listed on Schedule B (together with any transferees who become parties hereto as “Existing Stockholders” pursuant to Section 8(f), each individually, an “Existing Stockholder” and collectively, the “Existing Stockholders”), and (iv) Oneida Resources Corp., a Delaware corporation (“ORC”), but only for purposes of assuming all of the Company’s rights, duties and obligations hereunder pursuant to Section